Cyclophosphamide for Refractory Acute Cellular Rejection After Lung Transplantation

BACKGROUND: Acute cellular rejection (ACR) is a major risk factor for chronic lung allograft dysfunction after lung transplantation. Acute cellular rejection can persist or recur despite augmentation of immunosuppression by conventional methods. There are limited therapeutic options in treating thes...

Descripción completa

Detalles Bibliográficos
Autores principales: Naik, Chetan, Moore, Cody, Pipeling, Matthew, D’Cunha, Jonathan, Ruppert, Kristine, Ensor, Christopher, Morrell, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Lung Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959344/
https://www.ncbi.nlm.nih.gov/pubmed/29796421
http://dx.doi.org/10.1097/TXD.0000000000000790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959344/
https://www.ncbi.nlm.nih.gov/pubmed/29796421
http://dx.doi.org/10.1097/TXD.0000000000000790

Ejemplares similares